At the Blog
We continued a symposium on the future of cost-benefit analysis.
On Monday, Melissa Luttrell & Jorge Roman-Romero argued that, rather than attempt to fix or improve CBA, the ongoing modernization of regulatory analyses must focus on moving beyond the practice.
On Tuesday, Karen Tani underscored two points, long voiced by people who have experienced disability-based exclusion, about the limits of cost-benefit thinking.
And on Thursday, James Goodwin called for a progressive approach to regulatory analysis, and outlined what any such approach must include.
In LPE Land
At a panel we hosted on Wednesday, Dr. David Kessler, Chief Science Officer of the Biden COVID-19 Response Team, responded to questions from advocates focused on ending the global vaccine shortage. If you missed it, you can watch a video of the panel here.
And don’t miss our next event! On Friday, Oct. 22, we will be co-hosting a zoom panel on Property Rights Against Democracy: Implications of Cedar Point Nursery, with Niko Bowie, Veena Dubal, and Amy Kapczynski. Open to all, but please make sure to register here.
